<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35242128</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Rhinovirus-Induced Cytokine Alterations With Potential Implications in Asthma Exacerbations: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>782936</StartPage><MedlinePgn>782936</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">782936</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.782936</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Rhinovirus (RV) infections are a major cause of asthma exacerbations. Unlike other respiratory viruses, RV causes minimal cytotoxic effects on airway epithelial cells and cytokines play a critical role in its pathogenesis. However, previous findings on RV-induced cytokine responses were largely inconsistent. Thus, this study sought to identify the cytokine/chemokine profiles induced by RV infection and their correlations with airway inflammatory responses and/or respiratory symptoms using systematic review, and to determine whether a quantitative difference exists in cytokine levels between asthmatic and healthy individuals <i>via</i> meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Relevant articles were obtained from PubMed, Scopus, and ScienceDirect databases. Studies that compared RV-induced cytokine responses between asthmatic and healthy individuals were included in the systematic review, and their findings were categorized based on the study designs, which were <i>ex vivo</i> primary bronchial epithelial cells (PBECs), <i>ex vivo</i> peripheral blood mononuclear cells (PBMCs), and human experimental studies. Data on cytokine levels were also extracted and analyzed using Review Manager 5.4.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-four articles were included in the systematic review, with 18 of these further subjected to meta-analysis. Several studies reported the correlations between the levels of cytokines, such as IL-8, IL-4, IL-5, and IL-13, and respiratory symptoms. Evidence suggests that IL-25 and IL-33 may be the cytokines that promote type 2 inflammation in asthmatics after RV infection. Besides that, a meta-analysis revealed that PBECs from children with atopic asthma produced significantly lower levels of IFN-β [Effect size (ES): -0.84, <i>p</i> = 0.030] and IFN-λ (ES: -1.00, <i>p</i> = 0.002), and PBECs from adult atopic asthmatics produced significantly lower levels of IFN-β (ES: -0.68, <i>p</i> = 0.009), compared to healthy subjects after RV infection. A trend towards a deficient production of IFN-γ (ES: -0.56, <i>p</i> = 0.060) in PBMCs from adult atopic asthmatics was observed. In lower airways, asthmatics also had significantly lower baseline IL-15 (ES: -0.69, <i>p</i> = 0.020) levels.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Overall, RV-induced asthma exacerbations are potentially caused by an imbalance between Th1 and Th2 cytokines, which may be contributed by defective innate immune responses at cellular levels. Exogenous IFNs delivery may be beneficial as a prophylactic approach for RV-induced asthma exacerbations.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="BACKGROUND">https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=184119, identifier CRD42020184119.</AbstractText><CopyrightInformation>Copyright © 2022 Liew, Koh, Hooi, Ng, Chee, Harith, Israf and Tham.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liew</LastName><ForeName>Kong Yen</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Sue Kie</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooi</LastName><ForeName>Suet Li</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>School of Science, Monash University Malaysia, Subang Jaya, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Matthew Kah Lup</ForeName><Initials>MKL</Initials><AffiliationInfo><Affiliation>School of Science, Monash University Malaysia, Subang Jaya, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chee</LastName><ForeName>Hui-Yee</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harith</LastName><ForeName>Hanis Hazeera</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israf</LastName><ForeName>Daud Ahmad</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tham</LastName><ForeName>Chau Ling</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006969" MajorTopicYN="Y">Hypersensitivity, Immediate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">asthma</Keyword><Keyword MajorTopicYN="Y">chemokine</Keyword><Keyword MajorTopicYN="Y">cytokine</Keyword><Keyword MajorTopicYN="Y">exacerbation</Keyword><Keyword MajorTopicYN="Y">interferon</Keyword><Keyword MajorTopicYN="Y">meta-analysis</Keyword><Keyword MajorTopicYN="Y">rhinovirus</Keyword><Keyword MajorTopicYN="Y">systematic review</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35242128</ArticleId><ArticleId IdType="pmc">PMC8886024</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.782936</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Esneau C, Bartlett N, Bochkov YA. Rhinovirus Structure, Replication, and Classification. Rhinovirus Infect Rethink Impact Hum Heal Dis (2019) 1–23. doi: 10.1016/B978-0-12-816417-4.00001-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-816417-4.00001-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs SE, Lamson DM, Kirsten S, Walsh TJ. Human Rhinoviruses. Clin Microbiol Rev (2013) 26(1):135–62. doi: 10.1128/CMR.00077-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00077-12</ArticleId><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>Feddema JJ, Claassen E. Prevalence of Viral Respiratory Infections Amongst Asthmatics: Results of a Meta-Regression Analysis. Respir Med (2020) 173:106020. doi: 10.1016/j.rmed.2020.106020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106020</ArticleId><ArticleId IdType="pubmed">33190740</ArticleId></ArticleIdList></Reference><Reference><Citation>Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, et al. . Frequency, Severity, and Duration of Rhinovirus Infections in Asthmatic and non-Asthmatic Individuals: A Longitudinal Cohort Study. Lancet (2002) 359(9309):831–4. doi: 10.1016/S0140-6736(02)07953-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)07953-9</ArticleId><ArticleId IdType="pubmed">11897281</ArticleId></ArticleIdList></Reference><Reference><Citation>Grünberg K, Timmers MC, Smits HH, De Klerk EPA, Dick EC, Spaan WJM, et al. . Effect of Experimental Rhinovirus 16 Colds on Airway Hyperresponsiveness to Histamine and Interleukin-8 in Nasal Lavage in Asthmatic Subjects In Vivo . Clin Exp Allergy (1997) 27(1):36–45. doi: 10.1111/j.1365-2222.1997.tb00670.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.1997.tb00670.x</ArticleId><ArticleId IdType="pmc">PMC7164827</ArticleId><ArticleId IdType="pubmed">9117878</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunberg K, Timmers MC, de Klerk EP, Dick EC, Sterk PJ. Experimental Rhinovirus 16 Infection Causes Variable Airway Obstruction in Subjects With Atopic Asthma. Am J Respir Crit Care Med (1999) 160(4):1375–80. doi: 10.1164/ajrccm.160.4.9810083</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.160.4.9810083</ArticleId><ArticleId IdType="pubmed">10508832</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunberg K, Sharon RF, Sont JK, In‘t Veen JC, Van Schadewijk WA, De Klerk EP, et al. . Rhinovirus-Induced Airway Inflammation in Asthma: Effect of Treatment With Inhaled Corticosteroids Before and During Experimental Infection. Am J Respir Crit Care Med (2001) 164(10 Pt 1):1816–22. doi: 10.1164/ajrccm.164.10.2102118</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.164.10.2102118</ArticleId><ArticleId IdType="pubmed">11734429</ArticleId></ArticleIdList></Reference><Reference><Citation>Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, et al. . Rhinovirus-Induced Lower Respiratory Illness Is Increased in Asthma and Related to Virus Load and Th1/2 Cytokine and IL-10 Production. Proc Natl Acad Sci USA (2008) 105(36):13562–7. doi: 10.1073/pnas.0804181105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804181105</ArticleId><ArticleId IdType="pmc">PMC2528869</ArticleId><ArticleId IdType="pubmed">18768794</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ, et al. . Rhinoviruses Infect the Lower Airways. J Infect Dis (2000) 181(6):1875–84. doi: 10.1086/315513</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315513</ArticleId><ArticleId IdType="pubmed">10837165</ArticleId></ArticleIdList></Reference><Reference><Citation>Traves SL, Proud D. Viral-Associated Exacerbations of Asthma and COPD. Curr Opin Pharmacol (2007) 7(3):252–8. doi: 10.1016/j.coph.2006.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2006.11.010</ArticleId><ArticleId IdType="pmc">PMC7172261</ArticleId><ArticleId IdType="pubmed">17369093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov YA, Gern JE. Rhinoviruses and Their Receptors: Implications for Allergic Disease. Curr Allergy Asthma Rep (2016) 16(4):30–0. doi: 10.1007/s11882-016-0608-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-016-0608-7</ArticleId><ArticleId IdType="pmc">PMC4854667</ArticleId><ArticleId IdType="pubmed">26960297</ArticleId></ArticleIdList></Reference><Reference><Citation>Slater L, Bartlett NW, Haas JJ, Zhu J, Message SD, Walton RP, et al. . Role of TLR3, RIG-I and MDA5 in the Innate Response to Rhinovirus in Bronchial Epithelium. PloS Pathog (2010) 6(11):e1001178. doi: 10.1371/journal.ppat.1001178</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001178</ArticleId><ArticleId IdType="pmc">PMC2973831</ArticleId><ArticleId IdType="pubmed">21079690</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilarraza R, Wu Y, Skappak CD, Ajamian F, Proud D, Adamko DJ. Rhinovirus has the Unique Ability to Directly Activate Human T Cells In Vitro . J Allergy Clin Immunol (2013) 131(2):395–404. doi: 10.1016/j.jaci.2012.11.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2012.11.041</ArticleId><ArticleId IdType="pubmed">23374267</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang FSM, Hansbro PM, Burgess JK, Ammit AJ, Baines KJ, Oliver BG. Original Article: A Novel Immunomodulatory Function of Neutrophils on Rhinovirus-Activated Monocytes In Vitro . Thorax (2016) 71(11):1039. doi: 10.1136/thoraxjnl-2015-207781</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2015-207781</ArticleId><ArticleId IdType="pmc">PMC5099217</ArticleId><ArticleId IdType="pubmed">27287090</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubrail J, Gomez KA, Burgel PR, Mayer G, Kurian N, Niedergang F. Human Rhinovirus 16 Infection of Human Macrophages Significantly Impairs Their Phagocytic and Regulatory Functions: Implications in Understanding Chronic Inflammatory Lung Disease. Eur Respir J (2017) 50(suppl 61):OA286. doi: 10.1183/1393003.congress-2017.OA286</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/1393003.congress-2017.OA286</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Tan J, Liu J, Feng H, Pan D. Altered Mast Cell Activity in Response to Rhinovirus Infection Provides Novel Insight Into Asthma. J Asthma (2020) 57(5):459–67. doi: 10.1080/02770903.2019.1585870</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2019.1585870</ArticleId><ArticleId IdType="pubmed">30882256</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavala ML, Bertics PJ, Gern JE. Rhinoviruses, Allergic Inflammation, and Asthma. Immunol Rev (2011) 242(1):69. doi: 10.1111/j.1600-065X.2011.01031.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2011.01031.x</ArticleId><ArticleId IdType="pmc">PMC3119863</ArticleId><ArticleId IdType="pubmed">21682739</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. . Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015: Elaboration and Explanation. BMJ (2015) 349:g7647. doi: 10.1136/bmj.g7647</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the Sample Mean and Standard Deviation From the Sample Size, Median, Range and/or Interquartile Range. BMC Med Res Methodol (2014) 14(1):1–13. doi: 10.1186/1471-2288-14-135</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow ASF, Chik A, Soo K-M, Khoo LW, Abas F, Tham CL. Identification of Soluble Mediators in IgG-Mediated Anaphylaxis via Fcγ Receptor: A Meta-Analysis. Front Immunol (2019) 0:190. doi: 10.3389/fimmu.2019.00190</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00190</ArticleId><ArticleId IdType="pmc">PMC6379333</ArticleId><ArticleId IdType="pubmed">30809224</ArticleId></ArticleIdList></Reference><Reference><Citation>Suurmond R, van Rhee H, Hak T. Introduction, Comparison, and Validation of Meta-Essentials: A Free and Simple Tool for Meta-Analysis. Res Synth Methods (2017) 8(4):537. doi: 10.1002/jrsm.1260</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1260</ArticleId><ArticleId IdType="pmc">PMC5725669</ArticleId><ArticleId IdType="pubmed">28801932</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraldo S, Contoli M, Bazzan E, Turato G, Padovani A, Marku B, et al. . Deficient Antiviral Immune Responses in Childhood: Distinct Roles of Atopy and Asthma. J Allergy Clin Immunol (2012) 130(6):1307–14. doi: 10.1016/j.jaci.2012.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2012.08.005</ArticleId><ArticleId IdType="pubmed">22981791</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards MR, Regamey N, Vareille M, Kieninger E, Gupta A, Shoemark A, et al. . Impaired Innate Interferon Induction in Severe Therapy Resistant Atopic Asthmatic Children. Mucosal Immunol (2013) 6(4):797–806. doi: 10.1038/mi.2012.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2012.118</ArticleId><ArticleId IdType="pmc">PMC3684776</ArticleId><ArticleId IdType="pubmed">23212197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kicic A, Stevens PT, Sutanto EN, Kicic-Starcevich E, Ling K-M, Looi K, et al. . Impaired Airway Epithelial Cell Responses From Children With Asthma to Rhinoviral Infection. Clin Exp Allergy (2016) 46(11):1441–55. doi: 10.1111/cea.12767</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.12767</ArticleId><ArticleId IdType="pubmed">27238549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini B, Berthon BS, Starkey MR, Collison A, McLoughlin RF, Williams EJ, et al. . Children With Asthma Have Impaired Innate Immunity and Increased Numbers of Type 2 Innate Lymphoid Cells Compared With Healthy Controls. Front Immunol (2021) 12. doi: 10.3389/fimmu.2021.664668</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.664668</ArticleId><ArticleId IdType="pmc">PMC8248177</ArticleId><ArticleId IdType="pubmed">34220812</ArticleId></ArticleIdList></Reference><Reference><Citation>Iikura K, Katsunuma T, Saika S, Saito S, Ichinohe S, Ida H, et al. . Peripheral Blood Mononuclear Cells From Patients With Bronchial Asthma Show Impaired Innate Immune Responses to Rhinovirus In Vitro . Int Arch Allergy Immunol (2011) 155(Suppl):27–33. doi: 10.1159/000327262</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000327262</ArticleId><ArticleId IdType="pubmed">21646792</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskwa S, Piotrowski W, Marczak J, Pawelczyk M, Lewandowska-Polak A, Jarzebska M, et al. . Innate Immune Response to Viral Infections in Primary Bronchial Epithelial Cells Is Modified by the Atopic Status of Asthmatic Patients. Allergy Asthma Immunol Res (2018) 10(2):144–54. doi: 10.4168/aair.2018.10.2.144</Citation><ArticleIdList><ArticleId IdType="doi">10.4168/aair.2018.10.2.144</ArticleId><ArticleId IdType="pmc">PMC5809763</ArticleId><ArticleId IdType="pubmed">29411555</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurak LM, Xi Y, Landgraf M, Carroll ML, Murray L, Upham JW. Interleukin 33 Selectively Augments Rhinovirus-Induced Type 2 Immune Responses in Asthmatic But Not Healthy People. Front Immunol (2018) 9. doi: 10.3389/fimmu.2018.01895</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01895</ArticleId><ArticleId IdType="pmc">PMC6108046</ArticleId><ArticleId IdType="pubmed">30174671</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams TC, Jackson DJ, Maltby S, Walton RP, Ching Y-M, Glanville N, et al. . Rhinovirus-Induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6. Am J Respir Cell Mol Biol (2021) 64(3):344–56. doi: 10.1165/rcmb.2020-0011OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2020-0011OC</ArticleId><ArticleId IdType="pmc">PMC7909342</ArticleId><ArticleId IdType="pubmed">33264064</ArticleId></ArticleIdList></Reference><Reference><Citation>Cakebread JAA, Xu Y, Grainge C, Kehagia V, Howarth PHH, Holgate STT, et al. . Exogenous IFN-β has Antiviral and Anti-Inflammatory Properties in Primary Bronchial Epithelial Cells From Asthmatic Subjects Exposed to Rhinovirus. J Allergy Clin Immunol (2011) 127(5):1148–54.e9. doi: 10.1016/j.jaci.2011.01.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2011.01.023</ArticleId><ArticleId IdType="pubmed">21329968</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedke N, Sammut D, Green B, Kehagia V, Dennison P, Jenkins G, et al. . Transforming Growth Factor-Beta Promotes Rhinovirus Replication in Bronchial Epithelial Cells by Suppressing the Innate Immune Response. PloS One (2012) 7(9):e44580. doi: 10.1371/journal.pone.0044580</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044580</ArticleId><ArticleId IdType="pmc">PMC3435262</ArticleId><ArticleId IdType="pubmed">22970254</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai J, Smock SL, Jackson GR, MacIsaac KD, Huang Y, Mankus C, et al. . Phenotypic Responses of Differentiated Asthmatic Human Airway Epithelial Cultures to Rhinovirus. PloS One (2015) 10(2):e0118286. doi: 10.1371/journal.pone.0118286</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0118286</ArticleId><ArticleId IdType="pmc">PMC4338293</ArticleId><ArticleId IdType="pubmed">25706956</ArticleId></ArticleIdList></Reference><Reference><Citation>Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PAB, Bartlett NW, et al. . Role of Deficient Type III Interferon-Lambda Production in Asthma Exacerbations. Nat Med (2006) 12(9):1023–6. doi: 10.1038/nm1462</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1462</ArticleId><ArticleId IdType="pubmed">16906156</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons KS, Hsu AC, Wark PAB. TLR3 and MDA5 Signalling, Although Not Expression, Is Impaired in Asthmatic Epithelial Cells in Response to Rhinovirus Infection. Clin Exp Allergy (2014) 44(1):91–101. doi: 10.1111/cea.12218</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.12218</ArticleId><ArticleId IdType="pubmed">24131248</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov YA, Busse WW, Brockman-Schneider RA, Evans MD, Jarjour NN, McCrae C, et al. . Budesonide and Formoterol Effects on Rhinovirus Replication and Epithelial Cell Cytokine Responses. Respir Res (2013) 14(1):1–9. doi: 10.1186/1465-9921-14-98</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-14-98</ArticleId><ArticleId IdType="pmc">PMC3851834</ArticleId><ArticleId IdType="pubmed">24219422</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JH, Kim H, Jang YJ. Cigarette Smoke Extract Enhances Rhinovirus-Induced Toll-Like Receptor 3 Expression and Interleukin-8 Secretion in A549 Cells. J Rhinology Allergy (2009) 23(6):5–9. doi: 10.2500/ajra.2009.23.3407</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/ajra.2009.23.3407</ArticleId><ArticleId IdType="pubmed">19769802</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudy MHH, Traves SLL, Wiehler S, Proud D. Cigarette Smoke Modulates Rhinovirus-Induced Airway Epithelial Cell Chemokine Production [Internet]. Eur Respir J (2010) p:1256–63. doi: 10.1183/09031936.00128809</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00128809</ArticleId><ArticleId IdType="pubmed">19840959</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddleston J, Lee RU, Doerner AM, Herschbach J, Zuraw BL. Cigarette Smoke Decreases Innate Responses of Epithelial Cells to Rhinovirus Infection. Am J Respir Cell Mol Biol (2011) 44(1):118. doi: 10.1165/rcmb.2009-0266OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2009-0266OC</ArticleId><ArticleId IdType="pmc">PMC3028255</ArticleId><ArticleId IdType="pubmed">20224072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Souza N, Favoreto S, Wong H, Ward T, Yagi S, Schnurr D, et al. . In Vitro Susceptibility to Rhinovirus Infection Is Greater for Bronchial Than for Nasal Airway Epithelial Cells in Human Subjects. J Allergy Clin Immunol (2009) 123(6):1384–90. doi: 10.1016/j.jaci.2009.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2009.03.010</ArticleId><ArticleId IdType="pmc">PMC2744461</ArticleId><ArticleId IdType="pubmed">19428098</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark PABAB, Johnston SLL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. . Asthmatic Bronchial Epithelial Cells Have a Deficient Innate Immune Response to Infection With Rhinovirus [Internet]. J Exp Med (2005) 937–47. doi: 10.1084/jem.20041901</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20041901</ArticleId><ArticleId IdType="pmc">PMC2213100</ArticleId><ArticleId IdType="pubmed">15781584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark PABPAB, Bucchieri F, Johnston SLSL, Gibson PGPG, Hamilton L, Mimica J, et al. . IFN-Gamma-Induced Protein 10 Is a Novel Biomarker of Rhinovirus-Induced Asthma Exacerbations. J Allergy Clin Immunol (2007) 120(3):586–93. doi: 10.1016/j.jaci.2007.04.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2007.04.046</ArticleId><ArticleId IdType="pmc">PMC7127568</ArticleId><ArticleId IdType="pubmed">17628646</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE. Rhinovirus-Induced Modulation of Gene Expression in Bronchial Epithelial Cells From Subjects With Asthma. Mucosal Immunol (2010) 3(1):69–80. doi: 10.1038/mi.2009.109</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2009.109</ArticleId><ArticleId IdType="pmc">PMC2884103</ArticleId><ArticleId IdType="pubmed">19710636</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark PAB, Grissell T, Davies B, See H, Gibson PG. Diversity in the Bronchial Epithelial Cell Response to Infection With Different Rhinovirus Strains. Respirology (2009) 14(2):180–6. doi: 10.1111/j.1440-1843.2009.01480.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2009.01480.x</ArticleId><ArticleId IdType="pubmed">19207121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes A, Macintyre J, Edwards MRR, Del Rosario A, Haas J, Gielen V, et al. . Rhinovirus-Induced Interferon Production Is Not Deficient in Well-Controlled Asthma. Thorax (2014) 69(3):240–6. doi: 10.1136/thoraxjnl-2012-202909</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2012-202909</ArticleId><ArticleId IdType="pubmed">24127021</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark PAB, Bucchieri F, Johnston SL, Gibson PG, Hamilton L, Mimica J, et al. . IFN-γ-Induced Protein 10 is a Novel Biomarker of Rhinovirus-Induced Asthma Exacerbations. J Allergy Clin Immunol (2007) 120(3):586–93. doi: 10.1016/j.jaci.2007.04.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2007.04.046</ArticleId><ArticleId IdType="pmc">PMC7127568</ArticleId><ArticleId IdType="pubmed">17628646</ArticleId></ArticleIdList></Reference><Reference><Citation>Beale J, Jayaraman A, Jackson DJ, Macintyre JDR, Edwards MR, Walton RP, et al. . Rhinovirus-Induced IL-25 in Asthma Exacerbation Drives Type 2 Immunity and Allergic Pulmonary Inflammation. Sci Transl Med (2014) 6(256):256ra134. doi: 10.1126/scitranslmed.3009124</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3009124</ArticleId><ArticleId IdType="pmc">PMC4246061</ArticleId><ArticleId IdType="pubmed">25273095</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMore JP, Weisshaar EH, Vrtis RF, Swenson CA, Evans MD, Morin A, et al. . Similar Colds in Subjects With Allergic Asthma and Non-Atopic Subjects After Inoculation With Rhinovirus-16. J Allergy Clin Immunol (2009) 124(2):245–52. doi: 10.1016/j.jaci.2009.05.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2009.05.030</ArticleId><ArticleId IdType="pmc">PMC2737589</ArticleId><ArticleId IdType="pubmed">19596142</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. A Defective Type 1 Response to Rhinovirus in Atopic Asthma. Thorax (2002) 57(4):328–32. doi: 10.1136/thorax.57.4.328</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.57.4.328</ArticleId><ArticleId IdType="pmc">PMC1746310</ArticleId><ArticleId IdType="pubmed">11923551</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies JM, Carroll ML, Li H, Poh AM, Kirkegard D, Towers M, et al. . Budesonide and Formoterol Reduce Early Innate Antiviral Immune Responses In Vitro . PloS One (2011) 6(11):e27898. doi: 10.1371/journal.pone.0027898</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027898</ArticleId><ArticleId IdType="pmc">PMC3220700</ArticleId><ArticleId IdType="pubmed">22125636</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritchard AL, White OJ, Burel JG, Carroll ML, Phipps S, Upham JW. Asthma Is Associated With Multiple Alterations in Antiviral Innate Signalling Pathways. PloS One (2014) 9(9):e106501. doi: 10.1371/journal.pone.0106501</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0106501</ArticleId><ArticleId IdType="pmc">PMC4159236</ArticleId><ArticleId IdType="pubmed">25203745</ArticleId></ArticleIdList></Reference><Reference><Citation>Xatzipsalti M, Psarros F, Konstantinou G, Gaga M, Gourgiotis D, Saxoni-Papageorgiou P, et al. . Modulation of the Epithelial Inflammatory Response to Rhinovirus in an Atopic Environment. Clin Exp Allergy (2008) 38(3):466–72. doi: 10.1111/j.1365-2222.2007.02906.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.2007.02906.x</ArticleId><ArticleId IdType="pubmed">18269670</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes A, Edwards MR, MacIntyre J, Del Rosario A, Bakhsoliani E, Trujillo-Torralbo M-B, et al. . Rhinovirus 16-Induced IFN-α and IFN-β Are Deficient in Bronchoalveolar Lavage Cells in Asthmatic Patients. J Allergy Clin Immunol (2012) 129(6):1506–1514.e6. doi: 10.1016/j.jaci.2012.03.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2012.03.044</ArticleId><ArticleId IdType="pubmed">22657407</ArticleId></ArticleIdList></Reference><Reference><Citation>Upton N, Jackson DJ, Nikonova AA, Hingley-Wilson S, Khaitov M, Del Rosario A, et al. . Rhinovirus Induction of Fractalkine (CX3CL1) in Airway and Peripheral Blood Mononuclear Cells in Asthma. PloS One (2017) 12(8):e0183864. doi: 10.1371/journal.pone.0183864</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0183864</ArticleId><ArticleId IdType="pmc">PMC5578648</ArticleId><ArticleId IdType="pubmed">28859129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel TT, Tunstall T, Trujillo-Torralbo M-B, Shamji B, del-Rosario A, Dhariwal J, et al. . A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13). EBioMedicine (2017) 19:128–38. doi: 10.1016/j.ebiom.2017.03.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.03.033</ArticleId><ArticleId IdType="pmc">PMC5440599</ArticleId><ArticleId IdType="pubmed">28373098</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DJ, Makrinioti H, Rana BMJ, Shamji BWH, Trujillo-Torralbo MB, Footitt J, et al. . IL-33-Dependent Type 2 Inflammation During Rhinovirus-Induced Asthma Exacerbations In Vivo . Am J Respir Crit Care Med (2014) 190(12):1373–82. doi: 10.1164/rccm.201406-1039OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201406-1039OC</ArticleId><ArticleId IdType="pmc">PMC4299647</ArticleId><ArticleId IdType="pubmed">25350863</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming HE, Little FF, Schnurr D, Avila PC, Wong H, Liu J, et al. . Rhinovirus-16 Colds in Healthy and in Asthmatic Subjects: Similar Changes in Upper and Lower Airways. Am J Respir Crit Care Med (1999) 160(1):100–8. doi: 10.1164/ajrccm.160.1.9808074</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.160.1.9808074</ArticleId><ArticleId IdType="pubmed">10390386</ArticleId></ArticleIdList></Reference><Reference><Citation>De Kluijver J, Grünberg K, Pons D, De Klerk EPA, Dick CR, Sterk PJ, et al. . Interleukin-1β and Interleukin-1ra Levels in Nasal Lavages During Experimental Rhinovirus Infection in Asthmatic and Non-Asthmatic Subjects. Clin Exp Allergy (2003) 33(10):1415–8. doi: 10.1046/j.1365-2222.2003.01770.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2222.2003.01770.x</ArticleId><ArticleId IdType="pubmed">14519149</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohde G, Message SD, Haas JJ, Kebadze T, Parker H, Laza-Stanca V, et al. . CXC Chemokines and Antimicrobial Peptides in Rhinovirus-Induced Experimental Asthma Exacerbations. Clin Exp Allergy (2014) 44(7):930–9. doi: 10.1111/cea.12313</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.12313</ArticleId><ArticleId IdType="pmc">PMC4403958</ArticleId><ArticleId IdType="pubmed">24673807</ArticleId></ArticleIdList></Reference><Reference><Citation>Laza-Stanca V, Message SD, Edwards MR, Parker HL, Zdrenghea MT, Kebadze T, et al. . The Role of IL-15 Deficiency in the Pathogenesis of Virus-Induced Asthma Exacerbations. PloS Pathog (2011) 7(7):e1002114. doi: 10.1371/journal.ppat.1002114</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002114</ArticleId><ArticleId IdType="pmc">PMC3136447</ArticleId><ArticleId IdType="pubmed">21779162</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kluijver J, Grünberg K, Pons D, de Klerk EPA, Dick CR, Sterk PJ, et al. . Interleukin-1beta and Interleukin-1ra Levels in Nasal Lavages During Experimental Rhinovirus Infection in Asthmatic and Non-Asthmatic Subjects. Clin Exp Allergy J Br Soc Allergy Clin Immunol (2003) 33(10):1415–8. doi: 10.1046/j.1365-2222.2003.01770.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2222.2003.01770.x</ArticleId><ArticleId IdType="pubmed">14519149</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrecht BN, Hammad H, Fahy JV. The Cytokines of Asthma. Immunity (2019) 50:975–91. doi: 10.1016/j.immuni.2019.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.03.018</ArticleId><ArticleId IdType="pubmed">30995510</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy JL, Shaker M, McMeen V, Gern J, Carper H, Murphy D, et al. . Comparison of Viral Load in Individuals With and Without Asthma During Infections With Rhinovirus. Am J Respir Crit Care Med (2014) 189(5):532–9. doi: 10.1164/rccm.201310-1767OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201310-1767OC</ArticleId><ArticleId IdType="pmc">PMC3977713</ArticleId><ArticleId IdType="pubmed">24471509</ArticleId></ArticleIdList></Reference><Reference><Citation>Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PAB, Bartlett NW, et al. . Role of Deficient Type III Interferon-λ Production in Asthma Exacerbations. Nat Med (2006) 12(9):1023–6. doi: 10.1038/nm1462</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1462</ArticleId><ArticleId IdType="pubmed">16906156</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymann PW, Platts-Mills TAE, Woodfolk JA, Borish L, Murphy DD, Carper HT, et al. . Understanding the Asthmatic Response to an Experimental Rhinovirus Infection: Exploring the Effects of Blocking IgE. J Allergy Clin Immunol (2020) 146(3):545–54. doi: 10.1016/j.jaci.2020.01.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.01.035</ArticleId><ArticleId IdType="pmc">PMC7733370</ArticleId><ArticleId IdType="pubmed">32018030</ArticleId></ArticleIdList></Reference><Reference><Citation>Dienz O, Rincon M. The Effects of IL-6 on CD4 T Cell Responses. Clin Immunol (2009) 130(1):27. doi: 10.1016/j.clim.2008.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2008.08.018</ArticleId><ArticleId IdType="pmc">PMC2660866</ArticleId><ArticleId IdType="pubmed">18845487</ArticleId></ArticleIdList></Reference><Reference><Citation>Pease JE, Sabroe I. The Role of Interleukin-8 and its Receptors in Inflammatory Lung Disease: Implications for Therapy. Am J Respir Med (2002) 1(1):19. doi: 10.1007/BF03257159</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03257159</ArticleId><ArticleId IdType="pmc">PMC7102088</ArticleId><ArticleId IdType="pubmed">14720072</ArticleId></ArticleIdList></Reference><Reference><Citation>Wack A, Terczyńska-Dyla E, Hartmann R. Guarding the Frontiers: The Biology of Type III Interferons. Nat Immunol (2015) 16(8):802–9. doi: 10.1038/ni.3212</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3212</ArticleId><ArticleId IdType="pmc">PMC7096991</ArticleId><ArticleId IdType="pubmed">26194286</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I Interferons in Infectious Disease. Nat Rev Immunol (2015) 15(2):87–103. doi: 10.1038/nri3787</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Wang Y, Chang Q, Ma P, Hu Y, Cao X. Type III Interferons in Viral Infection and Antiviral Immunity. Cell Physiol Biochem (2018) 51(1):173–85. doi: 10.1159/000495172</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000495172</ArticleId><ArticleId IdType="pubmed">30439714</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AJ, Ashkar AA. The Dual Nature of Type I and Type II Interferons. Front Immunol (2018) 0(SEP):2061. doi: 10.3389/fimmu.2018.02061</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02061</ArticleId><ArticleId IdType="pmc">PMC6141705</ArticleId><ArticleId IdType="pubmed">30254639</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Yamane H, Paul WE. Differentiation of Effector CD4 T Cell Populations. Annu Rev Immunol (2010) 28:445. doi: 10.1146/annurev-immunol-030409-101212</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-030409-101212</ArticleId><ArticleId IdType="pmc">PMC3502616</ArticleId><ArticleId IdType="pubmed">20192806</ArticleId></ArticleIdList></Reference><Reference><Citation>Veerati PC, Troy NM, Reid AT, Li NF, Nichol KS, Kaur P, et al. . Airway Epithelial Cell Immunity Is Delayed During Rhinovirus Infection in Asthma and COPD. Front Immunol (2020) 11. doi: 10.3389/fimmu.2020.00974</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00974</ArticleId><ArticleId IdType="pmc">PMC7243842</ArticleId><ArticleId IdType="pubmed">32499788</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo S-K, Read J, Franks K, Zhang G, Bizzintino J, Coleman L, et al. . Upper Airway Cell Transcriptomics Identify a Major New Immunological Phenotype With Strong Clinical Correlates in Young Children With Acute Wheezing. J Immunol (2019) 202(6):1845–58. doi: 10.4049/jimmunol.1800178</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800178</ArticleId><ArticleId IdType="pubmed">30745463</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano JC, Carper HT, Rakes GP, Patrie J, Murphy DD, Platts-Mills TAE, et al. . Experimental Rhinovirus Challenges in Adults With Mild Asthma: Response to Infection in Relation to IgE. J Allergy Clin Immunol (2003) 111(5):1008–16. doi: 10.1067/mai.2003.1396</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mai.2003.1396</ArticleId><ArticleId IdType="pubmed">12743565</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperber SJ, Levine PA, Sorrentino JV, Riker DK, Hayden FG. Ineffectiveness of Recombinant Interferon-βserine Nasal Drops for Prophylaxis of Natural Colds. J Infect Dis (1989) 160(4):700. doi: 10.1093/infdis/160.4.700</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/160.4.700</ArticleId><ArticleId IdType="pmc">PMC7109997</ArticleId><ArticleId IdType="pubmed">2551976</ArticleId></ArticleIdList></Reference><Reference><Citation>Djukanovic R, Harrison T, Johnston SL, Gabbay F, Wark P, Thomson NC, et al. . The Effect of Inhaled IFN-β on Worsening of Asthma Symptoms Caused by Viral Infections. A Randomised Trial. Am J Respir Crit Care Med (2014) 190(2):145–54. doi: 10.1164/rccm.201312-2235OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201312-2235OC</ArticleId><ArticleId IdType="pmc">PMC4226052</ArticleId><ArticleId IdType="pubmed">24937476</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir AJ, Shiffman ML, Zaman A, Yoffe B, de la Torre A, Flamm S, et al. . Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients With Chronic Genotype 1 Hepatitis C Virus Infection. Hepatology (2010) 52(3):822–32. doi: 10.1002/hep.23743</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.23743</ArticleId><ArticleId IdType="pubmed">20564352</ArticleId></ArticleIdList></Reference><Reference><Citation>Feld JJ, Kandel C, Biondi MJ, Kozak RA, Zahoor MA, Lemieux C, et al. . Peginterferon Lambda for the Treatment of Outpatients With COVID-19: A Phase 2, Placebo-Controlled Randomised Trial. Lancet Respir Med (2021) 9(5):498–510. doi: 10.1016/S2213-2600(20)30566-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30566-X</ArticleId><ArticleId IdType="pmc">PMC7906707</ArticleId><ArticleId IdType="pubmed">33556319</ArticleId></ArticleIdList></Reference><Reference><Citation>Singanayagam A, Glanville N, Girkin JL, Ching YM, Marcellini A, Porter JD, et al. . Corticosteroid Suppression of Antiviral Immunity Increases Bacterial Loads and Mucus Production in COPD Exacerbations. Nat Commun (2018) 9(1):1–16. doi: 10.1038/s41467-018-04574-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04574-1</ArticleId><ArticleId IdType="pmc">PMC5993715</ArticleId><ArticleId IdType="pubmed">29884817</ArticleId></ArticleIdList></Reference><Reference><Citation>Adura PT, Reed E, Macintyre J, Del Rosario A, Roberts J, Pestridge R, et al. . Experimental Rhinovirus 16 Infection in Moderate Asthmatics on Inhaled Corticosteroids. Eur Respir J (2014) 43(4):1186–9. doi: 10.1183/09031936.00141713</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00141713</ArticleId><ArticleId IdType="pubmed">24311773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau SKP, Yip CCY, Lin AWC, Lee RA, So L-Y, Lau Y-L, et al. . Clinical and Molecular Epidemiology of Human Rhinovirus C in Children and Adults in Hong Kong Reveals a Possible Distinct Human Rhinovirus C Subgroup. J Infect Dis (2009) 200(7):1096–103. doi: 10.1086/605697</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605697</ArticleId><ArticleId IdType="pmc">PMC7199882</ArticleId><ArticleId IdType="pubmed">19708791</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Khuri-Bulos N, Williams JV, Shehabi AA, Faouri S, Al Jundi I, et al. . Human Rhinovirus C Associated With Wheezing in Hospitalised Children in the Middle East. J Clin Virol (2009) 46(1):85–9. doi: 10.1016/j.jcv.2009.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.06.007</ArticleId><ArticleId IdType="pmc">PMC2759319</ArticleId><ArticleId IdType="pubmed">19581125</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizzintino J, Lee WM, Laing IA, Vang F, Pappas T, Zhang G, et al. . Association Between Human Rhinovirus C and Severity of Acute Asthma in Children. Eur Respir J (2011) 37(5):1037–42. doi: 10.1183/09031936.00092410</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00092410</ArticleId><ArticleId IdType="pmc">PMC3024467</ArticleId><ArticleId IdType="pubmed">20693244</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagome K, Bochkov YA, Ashraf S, Brockman-Schneider RA, Evans MD, Pasic TR, et al. . Effects of Rhinovirus Species on Viral Replication and Cytokine Production. J Allergy Clin Immunol (2014) 134(2):332–41. doi: 10.1016/j.jaci.2014.01.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.01.029</ArticleId><ArticleId IdType="pmc">PMC4119842</ArticleId><ArticleId IdType="pubmed">24636084</ArticleId></ArticleIdList></Reference><Reference><Citation>Griggs TF, Bochkov YA, Basnet S, Pasic TR, Brockman-Schneider RA, Palmenberg AC, et al. . Rhinovirus C Targets Ciliated Airway Epithelial Cells. Respir Res (2017) 18(1):1–11. doi: 10.1186/s12931-017-0567-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-017-0567-0</ArticleId><ArticleId IdType="pmc">PMC5418766</ArticleId><ArticleId IdType="pubmed">28472984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy JL, Koziol-White CJ, Jeffus S, Rettiganti MR, Fisher P, Kurten M, et al. . Effects of Rhinovirus 39 Infection on Airway Hyperresponsiveness to Carbachol in Human Airways Precision Cut Lung Slices. J Allergy Clin Immunol (2018) 141(5):1887–1890.e1. doi: 10.1016/j.jaci.2017.11.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.11.041</ArticleId><ArticleId IdType="pmc">PMC5938135</ArticleId><ArticleId IdType="pubmed">29317243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirz OF, Jansen K, Satitsuksanoa P, van de Veen W, Tan G, Sokolowska M, et al. . Experimental Rhinovirus Infection Induces an Antiviral Response in Circulating B Cells Which Is Dysregulated in Patients With Asthma. Allergy Eur J Allergy Clin Immunol (2021) 77(1):130–42. doi: 10.1111/all.14985</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14985</ArticleId><ArticleId IdType="pmc">PMC10138744</ArticleId><ArticleId IdType="pubmed">34169553</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>